In a study comparing 6.4 million COVID-19 vaccine recipients with 4.6 million demographically similar unvaccinated persons, recipients of the Pfizer, Moderna or Janssen vaccines had lower non-COVID-19 mortality risk than did the unvaccinated comparison groups, the Centers for Disease Control and Prevention reported this week.

“There is no increased risk for mortality among COVID-19 vaccine recipients,” the authors said. “This finding reinforces the safety profile of currently approved COVID-19 vaccines in the United States.”

According to another study released this week by the CDC, adults under age 50 accounted for a larger proportion of patients hospitalized with COVID-19 after the delta variant became predominant, which the authors said was driven by the larger number of unvaccinated hospitalized patients in this age group.
 

Headline
The Department of Health and Human Services June 30 announced it will terminate emergency use authorization declarations for certain drugs and medical devices…
Headline
Centers for Medicare & Medicaid Services Administrator Mehmet Oz, M.D., and CMS Deputy Administrator and Director of Medicaid and CHIP Dan Brillman sat…
Headline
Flu and COVID-19 vaccination rates among all health care workers for the 2024-25 respiratory virus season was 76.3% and 40.2%, respectively, according to a…
Headline
A study published March 18 by Science Advances estimated that more than 155,000 U.S. COVID-19 deaths were uncounted during the COVID-19 pandemic. Researchers…
Headline
The Centers for Disease Control and Prevention Feb. 19 released a report on the low use of COVID-19 antiviral drugs among individuals age 65 and older, a…
Headline
The Food and Drug Administration today released two guidance documents; one related to low-risk wellness products (including certain wearable devices) and the…